Burow Kristina
SEC-identified person · CIK 1569248 Identifier-verified
Public-company roles (from insider filings)
| Company | Capacity as filed | Filings |
|---|---|---|
| Kardigan, Inc. KARD | Director | filed 2026 - 2026 |
| Scholar Rock Holding Corp SRRK | Director | filed 2018 - 2026 |
| Neumora Therapeutics, Inc. NMRA | Director | filed 2023 - 2026 |
| Seaport Therapeutics, Inc. SPTX | Officer | filed 2026 - 2026 |
| Lyell Immunopharma, Inc. LYEL | Officer | filed 2025 - 2026 |
| Metsera, Inc. MTSR | Director | filed 2025 - 2025 |
| Prime Medicine, Inc. PRME | Officer | filed 2022 - 2025 |
| Boundless Bio, Inc. BOLD | Director | filed 2024 - 2025 |
| Maze Therapeutics, Inc. MAZE | Officer | filed 2025 - 2025 |
| Rapport Therapeutics, Inc. RAPP | Officer | filed 2024 - 2024 |
| Sana Biotechnology, Inc. SANA | Officer | filed 2021 - 2024 |
| DA32 Life Science Tech Acquisition Corp. DALS | Officer | filed 2021 - 2023 |
| Gossamer Bio, Inc. GOSS | Director | filed 2019 - 2023 |
| Beam Therapeutics Inc. BEAM | Director | filed 2020 - 2023 |
| Erasca, Inc. ERAS | Officer | filed 2021 - 2021 |
| Unity Biotechnology, Inc. UBX | Director | filed 2018 - 2021 |
| Verve Therapeutics, Inc. VERV | Officer | filed 2021 - 2021 |
| Metacrine, Inc. MTCR | Director | filed 2020 - 2021 |
| Vir Biotechnology, Inc. VIR | Director | filed 2019 - 2020 |
| Sienna Biopharmaceuticals, Inc. SNNA | Director | filed 2017 - 2019 |
| Receptos, Inc. RCPT | Director | filed 2013 - 2015 |
All roles under one Commission-assigned identifier - the same person by the SEC's own record, not by name matching. From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.